(Total Views: 247)
Posted On: 11/03/2022 9:50:48 AM
Post# of 44

$AFMD News Article - Affimed Announces Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells and Preclinical AFM28 Data at ASH 2022 Annual Meeting https://marketwirenews.com/news-releases/affi...46377.html


My Twitter: WhyteStocks